<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Unlocking the Potential of miRNA in HIV Therapeutics</title>
  <link rel="stylesheet" href="../style.css" />
</head>
<body>
  <header>
    <nav class="navbar">
      <a href="../index.html">Home</a>
      <a href="../research-biography.html">Research Biography</a>
      <a href="../interests-goals.html">Interests & Goals</a>
      <div class="dropdown">
        <button class="dropbtn">Projects</button>
        <div class="dropdown-content">
          <a href="../projects/ongoing.html">Ongoing</a>
          <a href="../projects/past.html">Past</a>
        </div>
      </div>
      <a href="../thesis.html">Thesis</a>
      <a href="../publications.html">Publications</a>
      <a href="../certifications.html">Certifications</a>
      <a href="../blog.html" class="active">Blog</a>
      <a href="../contact.html">Contact</a>
    </nav>
  </header>

  <main class="container">
    <article class="blog-post">
      <h1>Unlocking the Potential of miRNA in HIV Therapeutics</h1>
      <p class="date">August 3, 2025</p>
      <p>
        HIV continues to pose a global health challenge despite remarkable advancements in antiretroviral therapy (ART). However, limitations such as viral persistence and latent reservoirs demand alternative approaches.
      </p>
      <p>
        One promising avenue involves targeting the <strong>Rev Response Element (RRE)</strong> â€“ a crucial RNA structure in the HIV genome that enables the export of unspliced viral RNA transcripts via the Rev protein.
      </p>
      <p>
        My recent work explores the use of microRNAs (miRNAs) to competitively bind with RRE and hinder Rev interaction, potentially disrupting viral replication.
      </p>
      <p>
        By applying secondary structure prediction tools and deep learning models trained on miRNA-target interactions, we can design artificial miRNAs that structurally and energetically outcompete Rev binding. This approach may lay the foundation for a new generation of RNA-based HIV therapies.
      </p>
    </article>
  </main>

  <footer>
    <p>&copy; 2025 Abdullah Al Marzan. All rights reserved.</p>
  </footer>
</body>
</html>
